The Food and Drug Administration on Thursday approved a core component of a brain implant made by Precision Neuroscience, a ...

Sanofi and Regeneron's fully human monoclonal antibody Dupixent (dupilumab) has gained approval from the US Food and Drug ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

In an interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven pathway that could be leveraged by rare disease therapies while saying that ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) for the treatment of chronic spontaneous ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The FDA clearance centers on the Layer 7 Cortical Interface, a wafer-thin, flexible electrode array designed to rest on the ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

Atai's financial resources appear sufficient to fund key milestones into late 2026, but future funding needs and potential ...

Rare diseases, often referred to as orphan diseases, affect small patient populations, yet collectively they impact more than ...

The AI model, called Damo Panda, was designed to detect early-stage pancreatic cancer using deep learning and abdominal CT ...